Literature DB >> 28668473

Multiple recurrences require long-term follow-up in patients diagnosed with spindle cell oncocytoma of the sella turcica.

Branavan Manoranjan1, Alex Koziarz2, Michelle M Kameda-Smith3, John P Provias4.   

Abstract

Spindle cell oncocytoma (SCO) of the sella turcica is characterized as a WHO grade I non-endocrine neoplasm of the sella turcica. Histologically, these tumors contain spindled and variably oncocytic cellular processes. Although SCOs lack immunoreactivity for neuroendocrine markers and pituitary hormones, they are clinically indistinguishable from non-functioning pituitary adenomas. In contrast to the initially described benign clinical course, several reports have subsequently illustrated cases with multiple recurrences with or without histological features of anaplasia in the form of nuclear pleomorphism, frequent mitoses, high Ki-67 index, and/or necrosis. With a follow-up of 14years, we report a case of SCO with multiple recurrences along with an exhaustive clinico-pathological review of all 41 cases of SCO reported in the literature, of which recurrence has been described in 11 cases. Collectively, this report highlights the importance of long-term follow-up and the possible need for adjuvant radiotherapy in patients diagnosed with a sellar SCO and provides a comprehensive review of this rare nonadenomatous sellar tumor.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Pituitary; Recurrence; Sellar tumor; Spindle cell oncocytoma

Mesh:

Year:  2017        PMID: 28668473     DOI: 10.1016/j.jocn.2017.05.017

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

Review 1.  Spindle cell oncocytoma of the pituitary gland.

Authors:  Alexandra M Giantini Larsen; David J Cote; Hasan A Zaidi; Wenya Linda Bi; Paul J Schmitt; J Bryan Iorgulescu; Michael B Miller; Timothy R Smith; M Beatriz Lopes; John A Jane; Edward R Laws
Journal:  J Neurosurg       Date:  2018-10-19       Impact factor: 5.115

Review 2.  Primary tumors of the posterior pituitary: A systematic review.

Authors:  Fernando Guerrero-Pérez; Agustina Pia Marengo; Noemi Vidal; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

3.  Pituitary spindle cell oncocytoma: illustrative case.

Authors:  Taha M Taka; Chen Yi Yang; Joshua N Limbo; Alvin Y Chan; Jordan Davies; Edward C Kuan; Scott G Turner; Frank P K Hsu
Journal:  J Neurosurg Case Lessons       Date:  2021-10-04

4.  Posterior pituitary tumours: patient outcomes and determinants of disease recurrence or persistence.

Authors:  Liza Das; Kim Vaiphei; Ashutosh Rai; Chirag Kamal Ahuja; Paramjeet Singh; Ishani Mohapatra; Rajesh Chhabra; Anil Bhansali; Bishan Dass Radotra; Ashley B Grossman; Márta Korbonits; Pinaki Dutta
Journal:  Endocr Connect       Date:  2021-04       Impact factor: 3.335

5.  Risk factors for tumor recurrence and progression of spindle cell oncocytoma of the pituitary gland: a systematic review and pooled analysis.

Authors:  Huy Gia Vuong; Truong Phan Xuan Nguyen; Nguyen Pham; Ian F Dunn
Journal:  Pituitary       Date:  2020-11-18       Impact factor: 4.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.